Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Link Between Statins, Non-CVD Outcomes Lacks Evidence
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — There is a lack of convincing evidence for an association between statin use and non-cardiovascular disease (CVD) outcomes, according to a review published in the Oct. 16 issue of the Annals of Internal Medicine.
Antibiotics, Acid Suppressants in Infancy May Up Obesity Risk
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — Prescription of antibiotics and acid-suppressing medications in early childhood is associated with an increased risk for obesity, according to a study published online Oct. 30 in Gut.
Peer Support Aids Patients With T2DM, Depressive Symptoms
TUESDAY, Oct. 30, 2018 (HealthDay News) — Peer support reduces hospitalizations for diabetes patients with depressive symptoms, according to a study published online Oct. 29 in Diabetes Care.
AMA Announces Initiative to Reinvent Physician Training
TUESDAY, Oct. 30, 2018 (HealthDay News) — The American Medical Association (AMA) today announced a new $15 million competitive grant initiative, the “Reimagining Residency” initiative, aimed at improving residency training.
Community Health Worker Intervention Beneficial
TUESDAY, Oct. 30, 2018 (HealthDay News) — A standardized community health worker (CHW)-delivered intervention, Individual Management for Patient-Centered Targets, improves patient-perceived quality of care and reduces hospitalizations for low-income patients with chronic diseases, according to a study published online Oct. 22 in JAMA Internal Medicine.
Many Hospitals Noncompliant With Record Request Regulations
MONDAY, Oct. 29, 2018 (HealthDay News) — Among top-ranked U.S. hospitals, data reveal discrepancies in information provided to patients regarding medical records release processes as well as noncompliance with state and federal regulations, according to a study published online Oct. 5 in JAMA Network Open.
Trump Administration Announces Plan to Cut Drug Prices
FRIDAY, Oct. 26, 2018 (HealthDay News) — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
Early Natural Menopause Linked to Shorter Life Expectancy